Lipoic acid improves survival in transgenic mouse models of Huntington's disease

被引：86

作者：

Andreassen, OA

Ferrante, RJ

Dedeoglu, A

Beal, MF

机构：

[1] Cornell Univ, Weill Med Coll, New York Hosp, Cornell Med Ctr,Dept Neurol & Neurosci, New York, NY 10021 USA

[2] Massachusetts Gen Hosp, Neurol Serv, Neurochem Lab, Boston, MA 02114 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Bedford VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA USA

[5] Boston Univ, Sch Med, Boston, MA 02118 USA

来源：

NEUROREPORT | 2001年 / 12卷 / 15期

关键词：

antioxidants; excitotoxicity; Huntington's disease; alpha-lipoic acid; transgenic mice;

D O I：

10.1097/00001756-200110290-00044

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

There is substantial evidence implicating excitotoxicity and oxidative damage in the pathogenesis of Huntington's disease (HD). We therefore examined whether the antioxidants 2-sulpho-tert-phenylbutyinitrone (S-PBN) and alpha -lipoic acid could exert neuroprotective effects in transgenic mouse models of HD. S-PBN showed no effects on either weight loss or survival in the R6/2 transgenic HD mice. alpha -Lipoic acid produced significant increases in survival in both R6/2 and N171-82Q transgenic mouse models of HD. These findings suggest that alpha -lipoic acid might have beneficial effects in HD patients. NeuroReport 12:3371-3373 (C) 2001 Lippincott Williams & Wilkins.

引用

页码：3371 / 3373

页数：3

共 50 条

[31] Striatal neurochemical changes in transgenic models of Huntington's disease
Ariano, MA
Aronin, N
Difiglia, M
Tagle, DA
Sibley, DR
Leavitt, BR
Hayden, MR
Levine, MS
[J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 68 (06) : 716 - 729
[32] Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease
Ferrante, RJ
Andreassen, OA
Dedeoglu, A
Ferrante, KL
Jenkins, BG
Hersch, SM
Beal, MF
[J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (05): : 1592 - 1599
[33] Knock-in mouse models of Huntington's disease
Menalled L.B.
[J]. NeuroRX, 2005, 2 (3): : 465 - 470
[34] Experimental therapeutics in mouse models of Huntington's disease
Hockly, E
Lupton, MK
Sunshine, S
Tse, J
Woodman, B
Bates, GP
Revington, AP
Lowden, PAS
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
[35] Transgenic mouse models of Alzheimer's disease
Sirinathsinghji, DJS
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (03) : 504 - 508
[36] Transgenic Mouse Models of Alzheimer's Disease
Elder, Gregory A.
Sosa, Miguel A. Gama
De Gasperi, Rita
[J]. MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (01): : 69 - 81
[37] Transgenic mouse models of Alzheimer's disease
Janus, C
Westaway, D
[J]. PHYSIOLOGY & BEHAVIOR, 2001, 73 (05) : 873 - 886
[38] Transgenic mouse models of Alzheimer's disease
Janus, C
Chishti, MA
Westaway, D
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 63 - 75
[39] Transgenic mouse models of Alzheimer's disease
Bornemann, KD
Staufenbiel, M
[J]. MOLECULAR AND CELLULAR GERONTOLOGY, 2000, 908 : 260 - 266
[40] Transgenic mouse models for Alzheimer's disease
Moechars, D
Lorent, K
Dewachter, I
Van Leuven, F
[J]. NOVEL SYSTEMS FOR THE STUDY OF HUMAN DISEASE: FROM BASIC RESEARCH TO APPLICATIONS, 1998, : 283 - 297

← 1 2 3 4 5 →